Dr. Emily Walden will join a panel of experts at the American Health Law Association’s Health Care Transactions Conference to discuss the growing scrutiny regulators are placing on vertical transactions in the healthcare industry. Recent transactions have blurred the lines between hospitals, physician groups, insurers, pharmacies, and IT vendors. 

Dr. Walden and other panelists will discuss:

• Business justification for vertical deals;
• How antitrust enforcers and economists assess vertical deals;
• Recent developments by the courts; and
• Strategies merging parties can employ to minimize antitrust risk through proactive deal planning and information safeguards.